cannabidiol and Torticollis

cannabidiol has been researched along with Torticollis* in 1 studies

Other Studies

1 other study(ies) available for cannabidiol and Torticollis

Article	Year
Open label evaluation of cannabidiol in dystonic movement disorders. The International journal of neuroscience, 1986, Volume: 30, Issue:4 Cannabidiol (CBD), a nonpsychoactive cannabinoid of Cannabis, was given to 5 patients with dystonic movement disorders in a preliminary open pilot study. Oral doses of CBD rising from 100 to 600 mg/day over a 6 week period were administered along with standard medication. Dose-related improvement in dystonia was observed in all patients and ranged from 20 to 50%. Side-effects of CBD were mild and included hypotension, dry mouth, psychomotor slowing, lightheadedness, and sedation. In 2 patients with coexisting Parkinsonian features, CBD at doses over 300 mg/day exacerbated the hypokinesia and resting tremor. CBD appears to have antidystonic and Parkinsonism-aggravating effects in humans. Topics: Adult; Aged; Cannabidiol; Cannabinoids; Dystonia; Dystonia Musculorum Deformans; Female; Humans; Levodopa; Male; Meige Syndrome; Middle Aged; Muscle Spasticity; Torticollis	1986

Article

Year

Open label evaluation of cannabidiol in dystonic movement disorders.

The International journal of neuroscience, 1986, Volume: 30, Issue:4

Cannabidiol (CBD), a nonpsychoactive cannabinoid of Cannabis, was given to 5 patients with dystonic movement disorders in a preliminary open pilot study. Oral doses of CBD rising from 100 to 600 mg/day over a 6 week period were administered along with standard medication. Dose-related improvement in dystonia was observed in all patients and ranged from 20 to 50%. Side-effects of CBD were mild and included hypotension, dry mouth, psychomotor slowing, lightheadedness, and sedation. In 2 patients with coexisting Parkinsonian features, CBD at doses over 300 mg/day exacerbated the hypokinesia and resting tremor. CBD appears to have antidystonic and Parkinsonism-aggravating effects in humans.

Topics: Adult; Aged; Cannabidiol; Cannabinoids; Dystonia; Dystonia Musculorum Deformans; Female; Humans; Levodopa; Male; Meige Syndrome; Middle Aged; Muscle Spasticity; Torticollis

1986